Anti-VEGF therapy for diabetic macular edema: up-to-date approaches to the management of patients with high and low baseline functional parameters
<p> <b>E.V. Bobykin</b> </p> <p> Ural State Medical University, Yekaterinburg, Russian Federation </p> <p> <br> </p> <p> Diabetic macular edema (DME) is a serious complication of diabetes mellitus (DM) and a vision-threatening conditi...
Saved in:
Main Author: | E.V. Bobykin |
---|---|
Format: | Article |
Language: | Russian |
Published: |
Prime-Media
2022-09-01
|
Series: | РМЖ "Клиническая офтальмология" |
Online Access: | http://clinopht.com/upload/iblock/e40/e403900960d031cb53fbb14c04132515.pdf |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Anti-VEGF agents for the treatment of diabetic macular edema
by: S.G. Sergushev, et al.
Published: (2019-11-01) -
Switch to Aflibercept in Diabetic Macular Edema Patients Unresponsive to Previous Anti-VEGF Therapy
by: Filipe Mira, et al.
Published: (2017-01-01) -
Prediction of Visual Acuity after anti-VEGF Therapy in Diabetic Macular Edema by Machine Learning
by: Ying Zhang, et al.
Published: (2022-01-01) -
Combination of Anti-VEGF and Laser Photocoagulation for Diabetic Macular Edema: A Review
by: Laura N. Distefano, et al.
Published: (2017-01-01) -
Adjunct Intravitreous Triamcinolone Acetonide in the Treatment of Diabetic Macular Edema with Anti-VEGF Agents
by: Robert B. Garoon, et al.
Published: (2016-01-01)